))
Telehealth and Biohacking: A Risky Combination
Manage episode 455809823 series 3506216
Indhold leveret af Darshan Kulkarni. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Darshan Kulkarni eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
The rise of biohacking has transitioned from a niche interest to a mainstream trend, particularly in the context of drugs like Ozempic and ketamine. While biohacking aims to enhance human performance and health, it raises significant questions about the risks and benefits, especially concerning telehealth services. Individuals are increasingly seeking prescriptions for medications traditionally used for specific medical conditions, such as diabetes, and utilizing them off-label for weight loss or mental health treatment without appropriate medical oversight.
This trend poses substantial risks, including misuse, adverse effects, and addiction, particularly with controlled substances like ketamine. Physicians face complex challenges as patients pursue these unregulated therapies, often without the necessary in-person examinations mandated in certain states. The lack of thorough patient assessments and informed consent raises concerns about liability, regulatory scrutiny, and potential malpractice claims.
As telehealth becomes more popular, the gap between patient autonomy and the physician's duty to do no harm widens. Physicians must navigate these evolving issues carefully, ensuring adequate oversight and understanding the risks associated with prescribing these powerful medications.
150 episoder
Del
